Mobilization of peripheral blood progenitor cells by Betafectinρ PGG- Glucan alone and in combination with granulocyte colony-stimulating factor

Stem Cells

Volumn 16, Issue 3, 1998, Pages 208-217

  Patchen, M L ^a   Liang, J ^a   Vaudrain, T ^a   Martin, T ^a   Melican, D ^a   Zhong, S ^b   Stewart, M ^b   Quesenberry, P J ^b  

^a Alpha Beta Technology Inc   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Betafectin ; Chemokines; G CSF; Hematopoiesis; Mobilization; Peripheral blood progenitor cells; PGG Glucan; Radioprotection; Reconstitution

Indexed keywords

BETAFECTIN; GLUCAN; GROWTH PROMOTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL KINETICS; CONTROLLED STUDY; FEMALE; GROWTH STIMULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; RADIATION PROTECTION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; PRIMATES; SACCHAROMYCES CEREVISIAE;

EID: 0031805238     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.160208     Document Type: Article

References (53)

1. Mangan K. Peripheral blood stem cell transplantation: from laboratory to clinical practice. Semin Oncol 1995;22:202-209.
2. Moolten DN. Peripheral blood stem cell transplant: future directions. Semin Oncol 1995;22:271-290.
3. Kessinger A. Do autologous peripheral blood cell transplants provide more than hematopoietic recovery? STEM CELLS 1995;13:351-354.
4. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995;85:1666-1672.
5. Boiron JM, Reiffers J, Lowenthal RM. Blood cell transplantation: past, present and future. Hematol Cell Ther 1996;38:399-407.
6. Stadtmauer EA, Schneider CJ, Silberstein LE. Peripheral blood progenitor cell generation and harvesting. Semin Oncol 1995;22:291-300.
7. Klumpp TR. Complications of peripheral blood stem cell transplantation. Semin Oncol 1995;22:263-270.
8. Niskanen EO, Burgaleta C, Cline MJ et al. Effect of glucan, a macrophage activator, on murine hemopoietic cell proliferation in diffusion chambers in mice. Cancer Res 1978;36:1406-1409.
9. Patchen ML, Lotzova E. Modulation of murine hemopoiesis by glucan. Exp Hematol 1980;8:409-422.
10. Patchen ML, MacVittie TJ. Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low dose glucan treatment. Acta Haematol 1983;70:281-288.
11. Patchen ML, MacVittie TJ. Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice. Int J Immunopharmacol 1985;7:923-932.
12. Patchen ML, MacVittie TJ. Hemopoietic effects of intravenous soluble glucan administration. J Immunopharmacol 1986;8:407-425.
13. Patchen ML, D'Alesandro MM, Brook I et al. Glucan: mechanisms involved in its "radioprotective" effect. J Leukoc Biol 1987;42:95-105.
14. Bowers GJ, Patchen ML, MacVittie TJ et al. A comparative evaluation of particulate and soluble glucan in an endotoxin model. Int J Immunopharmacol 1986;8:313-321.
15. Williams DA, Mueller A, Browder W. Glucan-based macrophage stimulators: a review of their anti-infective potential. Clin Immunother 1996;5:392-399.
16. Patchen ML, Lotzova E. The mechanism of glucan's action on hemopoiesis. Biomed 1981;34:71-77.
17. Sherwood ER, Williams DL, McNamee RB et al. Enhancement of interleukin-1 and interleukin-2 production by soluble glucan. Int J Immunopharmacol 1987;9:261-267.
18. Gallin EK, Green SW, Patchen ML. Comparable effects of particulate and soluble glucans on macrophages of C3H/HeN and C3H/HeJ mice. Int J Immunopharmacol 1992;14:173-183.
19. Browder W, Williams D, Pretus H et al. Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg 1990;11:605-613.
20. 4. Scand J Immunol 1990;32:333-340.
21. Bleicher P, Mackin W. Betafectin® PGG-Glucan: a novel carbohydrate immunomodulator with anti-infective properties. J Biotechnol in Healthcare 1995;2:207-222.
22. Nemunaitis J. Macrophage function activating cytokines: potential clinical application. Clin Rev Oncol/Hematol 1993;14:153-171.
23. Onderdonk AB, Cisneros RL, Hinkson P et al. Anti-infective effect of poly-β-1,6-glucotriosyl-β1,3 glucopyranose glucan in vivo. Infect Immun 1992;60:1642-1647.
24. Babineau TJ, Marcello P, Swails W et al. Randomized Phase I/II trial of a macrophage-specific immunomodulator (PGG-Glucan) in high risk surgical patients. Ann Surg 1994;220:601-609.
25. Poutsiaka DD, Mengozzi M, Vannier E et al. Cross-linking of the β-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production. Blood 1993;12:3695-3700.
26. Wakshull E, Correira H, Sidloski T. Synergistic stimulation of myeloid progenitor cell proliferation by a novel β-glucan and GM-CSF. J Cell Biochem 1994;18A:22.
27. Trunbull JL, Smart JL, Patchen ML et al. PGG-glucan is a non-protein based mediator of increased human CFU-GM production in vitro. Exp Hematol 1995;23:881.
28. Patchen ML, Wakshull E, Ostroff G et al. In vitro and in vivo hematopoietic effects of Betafectin® PGG-Glucan. Exp Hematol 1995;23:824.
29. Ramshaw HS, Rao SS, Crittenden RB et al. Engraftment of bone marrow cells into normal unprepared hosts: effect of 5-fluorouracil and cell cycle states. Blood 1995;86:924-929.
30. Patchen ML, MacVittie TJ, Solberg BD et al. Radioprotection by polysaccharides alone and in combination with aminothiols. Adv Space Res 1992;12:233-248.
31. Laterveer L, Lindley IJ, Hamilton MS et al. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995;85:2269-2275.
32. Laterveer L, Lindley IJD, Heemskerk DPM et al. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of Interleukin-8. Blood 1996;87:781-788.
33. Laterveer L, Zijlmans JM, Lindley IJD et al. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor. Exp Hematol 1996;24:1387-1393.
34. Demirer T, Buckner CD, Bensinger WI. Optimization of peripheral blood stem cell mobilization. STEM CELLS 1996;14:106-116.
35. Van Der Ham AC, Benner R, Vos O. Mobilization of bone marrow derived and thymic derived lymphocytes and hematopoietic stem cells by polymethacrylic acid and dextran sulfate. Cell Tissue Kinet 1977;10:387-397.
36. Wilschut JC, Erkens-Versluis ME, Ploemacher RE et al. The mechanisms of hematopoietic stem cell mobilization: a role of the complement system. Cell Tissue Kinet 1979;12:299-311.
37. Ross WM, Peeke J. Radioprotection conferred by dextran sulfate given before irradiation in mice. Exp Hematol 1986;14:147-155.
38. Jamas S, Easson DD, Ostroff G. Novel glucan preparation. (Patent) International Publication Number WO94/04163, 1994.
39. Park JT, Guo YA, Magee AS et al. Determination of aggregation number distribution (AND) of bio/polymers: a novel multidector SEC with post column delivery system. In: Proceedings of The American Chemical Society Division of Polymeric Materials. Science and Engineering, American Chemical Society, Washington, DC. abstr. 1997 (Fall).
40. Fleming WH, Alpern EJ, Uchida N et al. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci USA 1993;90:3760-3764.
41. Molineux G, Pojda Z, Hampson IN et al. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990;76:2153-2158.
42. Van XQ, Briddell R, Hartley C et al. Mobilization of long-term hematopoietic reconstituting cells in mice by the combination of stem cell factor plus granulocyte colony-stimulating factor. Blood 1994;84:795-799.
43. Papayannopoulou T, Craddock C. Homing and trafficking of hemopoietic progenitor cells. Acta Haematol 1997;97:97-104.
44. 4 induced hemopoietic progenitor (HP) peripheralization in primates. Blood 1994;84:22.
45. 4/VACA-1 adhesion pathway defines contrasting mechanisms of lodgment of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 1995;92:9647-9651.
46. 1 integrins expressed on hematopoietic cell lines. Blood 1995;85:159-167.
47. Lee J, Cacalano G, Camerato T et al. Chemokine binding and activities mediated by the mouse IL-8 receptor. J Immunol 1995;155:2158-2164.
48. Lord BI, Woolford LB, Wood LM et al. Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein 1α. Blood 1995;85:3412-3415.
49. Liu F, Poursine-Laurent J, Link DC. The granulocyte colonystimulating factor receptor is required for the mobilization of murine progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not Flt3 ligand. Blood 1997;90:2522-2528.
50. Molineux G, Pojda Z, Dexter TM. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 1990;75:563-569.
51. Briddell R, Hartley C, Stoney G et al. SCF synergizes with G-CSF in vivo to mobilize murine peripheral blood progenitor cells with enhanced engraftment potential. Exp Hematol 1993;21:1150-1156.
52. Drize N, Chertov J, Zander A. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Exp Hematol 1995;23:1180-1186.
53. Brasel K, McKenna HJ, Charrier K et al. Flt3 ligand synergizes with granulocyte-maerophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Blood 1997;90:3781-3788.